Yüklüyor......
Prevalence of Antibodies Against JC Virus in Serum of Patients With Refractory Crohn’s Disease and Effects of Natalizumab Therapy
BACKGROUND & AIMS: Natalizumab, a humanized antibody against the α4 integrin subunit, effectively induces and maintains remission in patients with Crohn’s disease (CD) refractory to conventional treatments. Progressive multi-focal leukoencephalopathy is a rare but fatal brain infection caused by...
Kaydedildi:
| Yayımlandı: | Clin Gastroenterol Hepatol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4795937/ https://ncbi.nlm.nih.gov/pubmed/26001336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2015.05.022 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|